Differential taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cells

Journal of Cell Biology

Volumn 135, Issue 3, 1996, Pages 689-700

  Trielli, Marc O ^a   Andreassen, Paul R ^a   Lacroix, Françoise B ^a   Margolis, Robert L ^a  

^a INSTITUT DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; NOCODAZOLE; PACLITAXEL; PHOSPHOPROTEIN; PROTEIN KINASE; VIRUS LARGE T ANTIGEN;

ANIMAL CELL; ARTICLE; CANCER CHEMOTHERAPY; CELL CYCLE G1 PHASE; CELL DEATH; CELL TRANSFORMATION; CONTROLLED STUDY; DEPHOSPHORYLATION; DNA CONTENT; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MAMMAL; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE; CELL LINE, TRANSFORMED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; CYCLINS; ENZYME INHIBITORS; FIBROBLASTS; G1 PHASE; HUMANS; HYDROXYUREA; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NOCODAZOLE; PACLITAXEL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RATS; RETINOBLASTOMA PROTEIN; SIMIAN VIRUS 40; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; MAMMALIA;

EID: 0029807822     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.135.3.689     Document Type: Article

References (61)

1. cdc2 inactivation and mitotic exit in mammalian cells. J. Cell Biol. 127:789-802.
2. Andreassen, P.R., D.K. Palmer, M.H. Wener, and R.L. Margolis. 1991. Telophase disc: a new mammalian mitotic organelle that bisects telophase cells with a possible function in cytokinesis. J. Cell Sci. 99:523-534.
3. Bhalla, K., A.M. Ibrado, E. Tourkina, C. Tang, M.E. Mahoney, and Y. Huang. 1993. Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia. 7:563-568.
4. Bravo, R., and H. MacDonald-Bravo. 1985. Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO (Eur. Mol. Biol. Organ.) J. 4:655-661.
5. Bravo, R., R. Frank, P.A. Blundell, and H. MacDonald-Bravo. 1987. Cyclin/PCNA is the auxiliary protein of DNA polymerase-δ. Nature (Lond.). 326: 515-517.
6. Brénot-Bosc, F., S. Gupta, R.L. Margolis, and R. Fotedar. 1995. Changes in the subcellular localization of replication initiation proteins and cell cycle proteins during G1- to S-phase transition in mammalian cells. Chromosoma. 103:517-527.
7. Buchkovich, K., L.A. Duffy, and E. Harlow. 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell. 58:1097-1105.
8. Chellappan, S.P., S. Hiebert, M. Mudryl, J.M. Horowitz, and J.R. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell. 65: 1053-1061.
9. Chen, P.-L., P. Scully, J.-Y. Shew, J.Y.J. Wang, and W.-H. Lee. 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell. 58:1193-1198.
10. Crossin, K.L., and D.H. Carney. 1981. Evidence that microtubule depolymerization early in the cell cycle is sufficient to initiate DNA synthesis. Cell. 23: 61-71.
11. DeCaprio, J.A., J.W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and D.M. Livingston. 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 58:1085-1095.
12. Deffie, A., M. Hao, R. Montes de Oca Luna, D.L. Hulboy, and G. Lozano. 1995. Cyclin E restores p53 activity in contact-inhibited cells. Mol. Cell. Biol. 15:3926-3933.
13. CIP1WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell. 82:675-684.
14. cdc2 coincident with Taxol-induced apoptosis. Cell Growth & Diff. 5: 1041-1050.
15. Donehower, L.A., M. Harvey, B.L. Slagle, M.J. McArthur, C.A. Montgomery Jr., J.S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (Lond.). 356: 215-221.
16. Dynlacht, B.D., O. Flores, J.A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes & Dev. 8:1772-1786.
17. Dyson, N., K. Buchkovich, P. Whyte, and E. Harlow. 1989. The cellular 107K protein that binds to adenovirus E1A also associates with the large T antigens of SV40 and JC virus. Cell. 58:249-255.
18. 1 arrest and apoptosis. Cancer Res. 54: 1169-1174.
19. Fang, F., and J.W. Newport. 1991. Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell. 66:731-742.
20. Gavrieli, Y., Y. Sherman, and S.A. Ben-Sasson. 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493-501.
21. Halevy, O., B.G. Novitch, D.B. Spicer, S.X. Skapek, J. Rhee, G.J. Hannon, D. Beach, and A.B. Lassar. 1995. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science (Wash. DC). 267: 1018-1021.
22. Harper, J.W., G.R. Adami, N. Wei, K. Keyomarsi, and S.J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:805-816.
23. Hartwell, L.H., and T.A. Weinert. 1989. Checkpoints: controls that ensure the order of cell cycle events. Science (Wash. DC). 246:629-634.
24. Hennequin, C., N. Giocanti, and V. Favaudon. 1995. S-phase specificity of cell killing by docetaxel (Taxotere) in synchronized HeLa cells. Br. J. Cancer. 71: 1194-1198.
25. Hiebert, S.W., S.P. Chelleppan, J.M. Horowitz, and J.R. Nevins. 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes & Dev. 6:177-185.
26. Hinds, P.W., S. Mittnacht, V. Dulic, A. Arnold, S.I. Reed, and R.A. Weinberg. 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993-1006.
27. Hinds, P.W., S.F. Dowdy, E.N. Eaton, A. Arnold, and R.A. Weinberg. 1994. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA. 91:709-713.
28. Hinds, P.W., and R.A. Weinberg. 1994. Tumor suppressor genes. Curr. Opin Genet. Dev. 4:135-141.
29. Hoebeke, J., G. Van Nijen, and M. De Brahander. 1976. Interaction of oncodazole (R 17934), a new anti-tumoral drug, with rat brain tubulin. Biochem. Biophys. Res. Commun. 69:319-324.
30. Hotz, M.A., J. Gong, F. Traganos, and Z. Darzynkiewicz. 1994. Flow cytometric detection of apoptosis: comparison of the assays of in situ DNA degradation and chromatin changes. Cytometry. 15:237-244.
31. Jacks, T., A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg. 1992. Effects of an Rb mutation in the mouse. Nature (Lond.). 359:295-300.
32. Jordan, M.A., D. Thrower, and L. Wilson. 1992. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles: implications for the role of microtubule dynamics in mitosis. J. Cell Sci. 102:401-416.
33. Jordan, M.A., R.J. Toso, D. Thrower, and L. Wilson. 1993. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA. 90:9552-9556.
34. Kastan, M.B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R.W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
35. Kuhiak, J.Z., M. Weber, H. de Pennart, N.J. Winston, and B. Maro. 1993. The metaphase II arrest in mouse oocytes is controlled through microtubule-dependent destruction of cyclin B in the presence of CSF. EMBO (Eur. Mol. Biol. Organ.) J. 12:3773-3778.
36. Kuerbitz, S.J., B.S. Plunkett, W.V. Walsh, and M.B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA. 89:7491-7495.
37. Lane, D.P., and L.V. Crawford. 1979. T antigen is hound to a host protein in SV40-transformed cells. Nature (Lond.). 278:261-263.
38. Linzer, D.I.H., and A.J. Levine. 1979. Characterization of a 54 K dalton cellular SV40 tumor antigen in SV40 transformed cells. Cell. 17:43-52.
39. Ludlow, J.W., J.A. DeCaprio, C.-M. Huang, W.H. Lee., E. Paucha, and D.M. Livingston. 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell. 56:57-65.
40. Mansour, S.J., W.T. Matten, A.S. Hermann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Vande Woude, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science (Wash. DC). 265:966-970.
41. Matsushime, H., D.E. Quelle, S.A. Shurtleff, M. Shibuya, C.J. Sherr, and J.-Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
42. McClain, D.A., and G.M. Edelman. 1980. Density-dependent stimulation and inhibition of cell growth by agents that disrupt microtubules. Proc. Natl. Acad. Sci. USA. 77:2748-2752.
43. Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature (Lond.). 372:570-573.
44. Ogata, K., P. Kurki, J.E. Celis, R.M. Nakamura, and E.M. Tan. 1987. Monoclonal antibodies to a nuclear protein (PCNA/cyclin) associated with DNA replication. Exp. Cell Res. 168:475-486.
45. Otto, A.M. 1987. Microtubules and DNA replication. Int. Rev. Cytol. 109:113-158.
46. Otto, A.M., M.O. Ulrich, A. Zumbe, and L. Jimenez de Asua. 1981. Microtubule disrupting agents affect two different events regulating the initiation of DNA synthesis in Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA. 78:3063-3067.
47. Pagano, M., R. Pepperkok, J. Lukas, V. Baldin, W. Ansorge, J. Bartek, and G. Draetta. 1993. Regulation of the cell cycle by the cdk2 protein kinase in cultured human fibroblasts. J. Cell Biol. 121:101-111.
48. Pagano, M., S.W. Tam, A.M. Theodoras, P. Beer-Romero, G. Del Sal, V. Chau, P.R. Yew, G.F. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science (Wash. DC). 269:682-685.
49. Perry, M.E., M. Commane, and G.R. Stark. 1992. Simian virus 40 large tumor antigen alone or two cooperating oncogenes convert REF52 cells to a state permissive for gene amplification. Proc. Natl. Acad. Sci. USA. 89:8112-8116.
50. KIP1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes & Dev. 8:9-22.
51. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitotic signals. Cell. 78:59-66.
52. Quartin, R.S., C.N. Cole, J.M. Pipas, and A.J. Levine. 1994. The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J. Virol. 68:1334-1341.
53. Rowinsky, E.K., and R.C. Donchower. 1995. Paclitaxel (Taxol). N. Engl. J. Med. 332:1004-1014.
54. Schiff, P.B., J. Fant, and S.B. Horwitz. 1979. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.). 277:665-667.
55. Sherr, C.J. 1994. G1 phase progression: cycling on cue. Cell. 79:551-555.
56. Toyoshima, H., and T. Hunter. 1994. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell. 78:67-74.
57. Tsai, L.-H., E. Lees, B. Faha, E. Harlow, and K. Riabowol. 1993. The cdk2 kinase is required for the G1-S transition in mammalian cells. Oncogene. 8: 1593-1602.
58. Wahl, A.F., K.L. Donaldson, C. Fairchild, F.Y.F. Lee, S.A. Foster, G.W. Demers, and D.A. Galloway. 1996. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nature Medicine. 2: 72-79.
59. 1 chinese hamster cells from entering the DNA synthetic period. Biochem. Biophys. Res. Commun. 69:212-217.
60. Weintraub, S.J., C.A. Prater, and D.C. Dean. 1992. Retinoblastoma protein switches the E2F site from positive to negative element. Nature (Lond.). 358: 259-261.
61. Zhu, J.Y., M. Abate, P.W. Rice, and C.N. Cole. 1991. The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J. Virol. 65:6871-6880.